Biofunctionalized gadolinium-containing Prussian blue nanoparticles as multimodal molecular imaging agents

Bioconjugate Chemistry

Volumn 25, Issue 1, 2014, Pages 129-137

  Dumont, Matthieu F ^a   Hoffman, Hilary A ^a   Yoon, Pryscilla R S ^a   Conklin, Laurie S ^a,c   Saha, Shanta R ^b   Paglione, Johnpierre ^b   Sze, Raymond W ^a,c   Fernandes, Rohan ^a,c  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CYTOLOGY; DIAGNOSIS; DISEASE CONTROL; FLUORESCENCE IMAGING; GADOLINIUM; GLYCOPROTEINS; MAGNETIC RESONANCE IMAGING; MOLECULAR IMAGING; SYNTHESIS (CHEMICAL);

CELLULARS; DISEASE DIAGNOSIS; EPITHELIAL CELLS; FLUORESCENCE IMAGING; GADOLINIA; IMAGING AGENT; MULTI-MODAL; PRUSSIAN BLUE NANOPARTICLES; RELAXIVITY; SUB-CELLULAR;

NANOPARTICLES;

FERRIC FERROCYANIDE; GADOLINIUM CONTAINING PRUSSIAN BLUE NANOPARTICLE; GADOLINIUM PENTETATE MEGLUMINE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; UNCLASSIFIED DRUG; CONTRAST MEDIUM; FERROCYANIDE; GADOLINIUM; NANOPARTICLE;

ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG SYNTHESIS; MOLECULAR IMAGING; MULTIMODAL IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; SQUAMOUS EPITHELIUM; CHEMISTRY; CYTOLOGY; EOSINOPHIL; EPITHELIUM CELL; FLUORESCENCE; HUMAN;

CONTRAST MEDIA; EOSINOPHILS; EPITHELIAL CELLS; FERROCYANIDES; FLUORESCENCE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; NANOPARTICLES;

EID: 84892737070     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc4004266     Document Type: Article

References (39)

1. Meade, T. J. and Aime, S. (2009) Chemistry of molecular imaging Acc. Chem. Res. 42, 821-821
2. James, M. L. and Gambhir, S. S. (2012) A molecular imaging primer: modalities, imaging agents, and applications Physiol. Rev. 92, 897-965
3. Louie, A. (2010) Multimodality imaging probes: design and challenges Chem. Rev. 110, 3146-3195
4. van Dam, G. M., Themelis, G., Crane, L. M. A., Harlaar, N. J., Pleijhuis, R. G., Kelder, W., Sarantopoulos, A., de Jong, J. S., Arts, H. J. G., van der Zee, A. G. J., Bart, J., Low, P. S., and Ntziachristos, V. (2011) Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results Nat. Med. 17, 1315-1319
5. Chekina, N., Horák, D., Jendelová, P., Trchová, M., Beneš, M. J., Hrubý, M., Herynek, V., Turnovcová, K., and Syková, E. (2011) Fluorescent magnetic nanoparticles for biomedical applications J. Mater. Chem. 21, 7630-7639
6. Frangioni, J. V. (2008) New technologies for human cancer imaging J. Clin. Oncol. 26, 4012-4021
7. Http://bayerimaging.com/products/magnevist/.
8. Http://imaging.bracco.com/us-en/products-and-solutions/contrast-media/ prohance.
9. Liang, G., Ronald, J., Chen, Y., Ye, D., Pandit, P., Ma, M. L., Rutt, B., and Rao, J. (2011) Controlled self-assembling of gadolinium nanoparticles as smart molecular magnetic resonance imaging contrast agents Angew. Chem., Int. Ed. 50, 6283-6286
10. Broz, P., Ben-Haim, N., Santini, F., Marsch, S., Scheffler, K., Meier, W., and Hunziker, P. (2009) Nano imaging technologies: polymer vesicles loaded with precipitated gadolinium nanoparticles: a novel target-specific contrast agent for magnetic resonance imaging Eur. J. Nanomedicine 2, 3-49
11. Hifumi, H., Yamaoka, S., Tanimoto, A., Citterio, D., and Suzuki, K. (2006) Gadolinium-based hybrid nanoparticles as a positive MR contrast agent J. Am. Chem. Soc. 128, 15090-15091
12. Dumont, M. F., Baligand, C., Li, Y., Knowles, E. S., Meisel, M. W., Walter, G. A., and Talham, D. R. (2012) DNA surface modified gadolinium phosphate nanoparticles as MRI contrast agents Bioconjugate Chem. 23, 951-957
13. Hou, S., Tong, S., Zhou, J., and Bao, G. (2012) Block copolymer-based gadolinium nanoparticles as MRI contrast agents with high T1 relaxivity Nanomedicine 7, 211-218
14. Korkusuz, H., Ulbrich, K., Welzel, K., Koeberle, V., Watcharin, W., Bahr, U., Chernikov, V., Knobloch, T., Petersen, S., Huebner, F., Ackermann, H., Gelperina, S., Kromen, W., Hammerstingl, R., Haupenthal, J., Gruenwald, F., Fiehler, J., Zeuzem, S., Kreuter, J., Vogl, T. J., and Piiper, A. (2013) Transferrin-coated gadolinium nanoparticles as MRI contrast agent Mol. Imaging Biol. 15, 148-154
15. Shokouhimehr, M. (2010) Prussian Blue Nanoparticles and Its Analogues as New-Generation T1-Weighted MRI Contrast Agents for Cellular Imaging, Kent State University.
16. Shokouhimehr, M., Soehnlen, E. S., Hao, J., Griswold, M., Flask, C., Fan, X., Basilion, J. P., Basu, S., and Huang, S. D. (2010) Dual purpose prussian blue nanoparticles for cellular imaging and drug delivery: a new generation of T1-weighted MRI contrast and small molecule delivery agents J. Mater. Chem. 20, 5251-5259
17. Bulte, J. W. M. and Kraitchman, D. L. (2004) Iron oxide MR contrast agents for molecular and cellular imaging NMR Biomed. 17, 484-499
18. Morana, G., Salviato, E., and Guarise, A. (2007) Contrast agents for hepatic MRI Cancer Imaging 7, S24-27
19. Aime, S., Castelli, D. D., Crich, S. G., Gianolio, E., and Terreno, E. (2009) Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications Acc. Chem. Res. 42, 822-831
20. Sapsford, K. E., Algar, W. R., Berti, L., Gemmill, K. B., Casey, B. J., Oh, E., Stewart, M. H., and Medintz, I. L. (2013) Functionalizing nanoparticles with biological molecules: developing chemistries that facilitate nanotechnology Chem. Rev. 113, 1904-2074
21. Dellon, E. S., Chen, X., Miller, C. R., Woosley, J. T., and Shaheen, N. J. (2012) Diagnostic utility of major basic protein, eotaxin-3, and leukotriene enzyme staining in eosinophilic esophagitis Am. J. Gastroenterol. 107, 1503-1511
22. Nakamoto, K. (2009) Infrared and Raman Spectra of Inorganic and Coordination Compounds, 6 th ed., Wiley, Hoboken, N.J.
23. Zhou, X., Wong, W.-T., Faucher, M. D., and Tanner, P. A. (2008) Crystallographic and infrared spectroscopic study of bond distances in Ln[Fe(CN)(6)]·4H(2)O (Ln = Lanthanide) J. Solid State Chem. 181, 3057-3064
24. Uemura, T., Ohba, M., and Kitagawa, S. (2004) Size and surface effects of prussian blue nanoparticles protected by organic polymers Inorg. Chem. 43, 7339-7345
25. Wojdeł, J. C. and Bromley, S. T. (2006) Band gap variation in prussian blue via cation-induced structural distortion J. Phys. Chem. B 110, 24294-24298
26. Cafun, J.-D., Champion, G., Arrio, M.-A., dit Moulin, C. C., and Bleuzen, A. (2010) Photomagnetic CoFe Prussian blue analogues: role of the cyanide ions as active electron transfer bridges modulated by cyanide-alkali metal ion interactions J. Am. Chem. Soc. 132, 11552-11559
27. Pintaske, J., Martirosian, P., Graf, H., Erb, G., Lodemann, K.-P., Claussen, C. D., and Schick, F. (2006) Relaxivity of gadopentetate dimeglumine (magnevist), gadobutrol (gadovist), and gadobenate dimeglumine (multihance) in human blood plasma at 0.2, 1.5, and 3 T Invest. Radiol. 41, 213-221
28. Runge, V. M., Biswas, J., Wintersperger, B. J., Baumann, S. S., Jackson, C. B., Herborn, C. U., and Patel, T. (2006) The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 T in brain magnetic resonance imaging Invest. Radiol. 41, 244-248
29. Barge, A., Cravotto, G., Gianolio, E., and Fedeli, F. (2006) How to determine free Gd and free ligand in solution of Gd chelates. a technical note Contr. Media Mol. Imaging 1, 184-188
30. Dumont, M. F., Knowles, E. S., Guiet, A., Pajerowski, D. M., Gomez, A., Kycia, S. W., Meisel, M. W., and Talham, D. R. (2011) Photoinduced magnetism in core/shell prussian blue analogue heterostructures of KjNik[Cr(CN)6] l·nH2O with RbaCob[Fe(CN)6]c·mH2O Inorg. Chem. 50, 4295-4300
31. Catala, L., Brinzei, D., Prado, Y., Gloter, A., Stéphan, O., Rogez, G., and Mallah, T. (2009) Core-multishell magnetic coordination nanoparticles: toward multifunctionality on the nanoscale Angew. Chem., Int. Ed. 48, 183-187
32. Jaiswal, J. K., Mattoussi, H., Mauro, J. M., and Simon, S. M. (2002) Long-term multiple color imaging of live cells using quantum dot bioconjugates Nat. Biotechnol. 21, 47-51
33. Goldman, E. R., Balighian, E. D., Mattoussi, H., Kuno, M. K., Mauro, J. M., Tran, P. T., and Anderson, G. P. (2002) Avidin: a natural bridge for quantum dot-antibody conjugates J. Am. Chem. Soc. 124, 6378-6382
34. Orita, T., Tomita, M., Harada, M., and Kato, K. (2012) Binding activity of avidin to the biotin within mesoporous silica materials for bioanalytical applications Anal. Biochem. 425, 1-9
35. Bayer, E. A. and Wilchek, M. (2006) The Use of the Avidin-Biotin Complex as a Tool in Molecular Biology. In Methods of Biochemical Analysis (Glick, D., Ed.) pp 1-45, Vol. 26, John Wiley & Sons, Inc., Hoboken, NJ, USA.
36. DeLange, R. J. and Huang, T. S. (1971) Egg White Avidin. 3. Sequence of the 78-residue middle cyanogen bromide peptide. complete amino acid sequence of the protein subunit J. Biol. Chem. 246, 698-709
37. Sun, S., Huang, X., Ma, M., Qiu, N., Cai, Z., Luo, Z., and Alies, N. P. (2012) Systematic evaluation of avidin-biotin interaction by fluorescence spectrophotometry Spectrochim. Acta, Part A 89, 99-104
38. Green, N. M. (1963) Avidin. 4. Stability at extremes of pH and dissociation into sub-units by guanidine hydrochloride Biochem. J. 89, 609-620
39. Fraenkel-Conrat, H., Snell, N. S., and Ducay, E. D. (1952) Avidin. II. Composition and mode of action of Avidin A Arch. Biochem. Biophys. 39, 97-107